{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:40:18Z","timestamp":1772674818306,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Vicerrector\u00eda de Investigaci\u00f3n y Extensi\u00f3n (VIE) from Universidad Industrial de Santander and Colciencias-Colombia","award":["1102-5453-1674"],"award-info":[{"award-number":["1102-5453-1674"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11274-015-1933-z","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T08:33:03Z","timestamp":1441182783000},"page":"1801-1809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species"],"prefix":"10.1007","volume":"31","author":[{"given":"Jhon J.","family":"Artunduaga Bonilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daissy J.","family":"Paredes Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara I.","family":"S\u00e1nchez Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia C.","family":"Ortiz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo G.","family":"Torres S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"1933_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2013.00074","volume":"3","author":"S Abbes","year":"2013","unstructured":"Abbes S, Mary C, Sellami H et al (2013) Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata. Front Cell Infect Microbiol 3:1\u20138","journal-title":"Front Cell Infect Microbiol"},{"key":"1933_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.arabjc.2010.04.008","volume":"3","author":"K Abou","year":"2010","unstructured":"Abou K, Eftaiha A, Al-Warthan A, Ammar R (2010) Synthesis and applications of silver nanoparticles. Arab J Chem 3:135\u2013140","journal-title":"Arab J Chem"},{"key":"1933_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jb\/mvg111","volume":"134","author":"M Almofti","year":"2003","unstructured":"Almofti M, Ichikawa T, Yamashita K, Terada H, Shinohara Y (2003) Silver ion induces a cyclosporine a-insensitive permeability transition in rat liver mitochondria and release of apoptogenic cytochrome C. J Biochem 134:43\u201349","journal-title":"J Biochem"},{"key":"1933_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12030-009-9029-1","volume":"5","author":"N Ayala","year":"2009","unstructured":"Ayala N, Lara H, Ixtepan L, Rodr\u00edguez C (2009) Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoescale does matter. Nanobiotechnology 5:2\u20139","journal-title":"Nanobiotechnology"},{"key":"1933_CR5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"A Barbara","year":"2013","unstructured":"Barbara A, Melissa J, Christopher P et al (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724\u20131732","journal-title":"Clin Infect Dis"},{"key":"1933_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2014.02.008","volume":"79","author":"R Ben-Ami","year":"2014","unstructured":"Ben-Ami R, Hilerowicz Y, Novikov A, Giladi M (2014) The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods. Diagn Microbiol Infect Dis 79:209\u2013213","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1933_CR7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/bjc.1988.125","volume":"57","author":"J Carmichael","year":"1988","unstructured":"Carmichael J, Mitchell J, DeGraff W et al (1988) Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 57:540\u2013547","journal-title":"Br J Cancer"},{"key":"1933_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1130-1406(06)70012-2","volume":"23","author":"M Catal\u00e1n","year":"2006","unstructured":"Catal\u00e1n M, Montejo J (2006) Systemic antifungals. Pharmacodynamia and pharmacokinetics. Rev Iberoam Micol 23:39\u201349","journal-title":"Rev Iberoam Micol"},{"key":"1933_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/nnm.11.78","volume":"6","author":"M Charles","year":"2011","unstructured":"Charles M, Wei Q, Scott E et al (2011) Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (London) 6:879\u2013898","journal-title":"Nanomedicine (London)"},{"key":"1933_CR10","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.watres.2008.02.021","volume":"42","author":"O Choi","year":"2008","unstructured":"Choi O, Deng K, Kim N et al (2008) The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42:3066\u20133074","journal-title":"Water Res"},{"key":"1933_CR11","volume-title":"Document M27-A3: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard \u2013","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008) Document M27-A3: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard \u2013, 3\u00aa edn. Pennsylvania, USA","edition":"3\u00aa"},{"key":"1933_CR12","doi-asserted-by":"crossref","first-page":"32278","DOI":"10.1371\/journal.pone.0032278","volume":"7","author":"M Desnos-Ollivier","year":"2012","unstructured":"Desnos-Ollivier M, Robert V, Raoux-Barbot D et al (2012) Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens. PLoS One 7:32278","journal-title":"PLoS One"},{"key":"1933_CR13","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1021\/la060661v","volume":"22","author":"S Gogoi","year":"2006","unstructured":"Gogoi S, Gopinath P, Paul A et al (2006) Green fluorescent protein-expressing escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 22:9322\u20139328","journal-title":"Langmuir"},{"key":"1933_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nano.2011.05.007","volume":"8","author":"M Guzman","year":"2012","unstructured":"Guzman M, Dille J, Godet S (2012) Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine 8:37\u201345","journal-title":"Nanomedicine"},{"key":"1933_CR15","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.00148-06","volume":"50","author":"M Hakki","year":"2006","unstructured":"Hakki M, Staab J, Marr K (2006) Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy. Antimicrob Agents Chemother 50:2522\u20132524","journal-title":"Antimicrob Agents Chemother"},{"key":"1933_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1166\/jbt.2013.1065","volume":"3","author":"L Higa","year":"2013","unstructured":"Higa L, Schilrreff P, Perez A, Morilla M, Romero E (2013) The intervention of nanotechnology against epithelial fungal diseases. J Biomater Tissue Eng 3:70\u201388","journal-title":"J Biomater Tissue Eng"},{"key":"1933_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tim.2013.04.002","volume":"21","author":"G Huffnagle","year":"2013","unstructured":"Huffnagle G, Noverr M (2013) The emerging world of the fungal microbiome. Trends Microbiol 21:334\u2013341","journal-title":"Trends Microbiol"},{"key":"1933_CR18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","volume":"156","author":"J Huh","year":"2011","unstructured":"Huh J, Jik Y (2011) \u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156:128\u2013145","journal-title":"J Control Release"},{"key":"1933_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/0074-0276130269","volume":"109","author":"K Ishida","year":"2014","unstructured":"Ishida K, Cipriano T, Rocha G et al (2014) Silver nanoparticle production by the fungus Fusarium oxysporum: nanoparticle characterisation and analysis of antifungal activity against pathogenic yeasts. Mem Inst Oswaldo Cruz 109:220\u2013228","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1933_CR20","first-page":"65","volume":"52","author":"A Jebali","year":"2014","unstructured":"Jebali A, Esmaeil F, Pourdanesh F, Hekmatimoghaddam S, Kazemi B et al (2014) Silver and gold nanostructures: antifungal property of different shapes of these nanostructures on Candida species. Med Mycol 52:65\u201372","journal-title":"Med Mycol"},{"key":"1933_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"Z Kanafani","year":"2008","unstructured":"Kanafani Z, Perfect J (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Res Infect Dis 46:120\u2013128","journal-title":"Clin Res Infect Dis"},{"key":"1933_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.colsurfa.2009.09.045","volume":"352","author":"Z Khan","year":"2009","unstructured":"Khan Z, Tnabaiti T, Mossalamy E, Yousif A (2009) Effect of macromolecule poly (vinyl alcohol) on the growth of cetyltrimethylammonium bromide stabilized Ag-nanoparticles. Colloids Surf A Physicochem Eng Asp 352:31\u201337","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"1933_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molcata.2003.09.047","volume":"223","author":"S Kumar","year":"2004","unstructured":"Kumar S, Nagaraja B, Shashikala V et al (2004) Highly efficient Ag\/C catalyst prepared by electro-chemical deposition method in controlling microorganisms in water. J Mol Catal A Chem 223:313\u2013319","journal-title":"J Mol Catal A Chem"},{"key":"1933_CR24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/pr0504079","volume":"5","author":"C Lok","year":"2006","unstructured":"Lok C, Chen R, Yu W et al (2006) Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteom Res 5:916\u2013924","journal-title":"J Proteom Res"},{"key":"1933_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0036-46652015000200011","volume":"57","author":"E Mallmann","year":"2015","unstructured":"Mallmann E, Cunha F, Castro B, Maciel A et al (2015) Antifungal activity of silver nanoparticles obtained by Green synthesis. Rev Inst Med Trop Sao Paulo 57:165\u2013167","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1933_CR26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"M Miceli","year":"2011","unstructured":"Miceli M, D\u00edaz J, Lee S (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11:142\u2013151","journal-title":"Lancet Infect Dis"},{"key":"1933_CR27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1586\/eci.12.52","volume":"8","author":"M Mikulska","year":"2012","unstructured":"Mikulska M, Del Bono B, Ratto S, Viscoli C (2012) Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol 8:755\u2013765","journal-title":"Expert Rev Clin Immunol"},{"key":"1933_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.apsusc.2014.01.166","volume":"298","author":"A Mocanua","year":"2014","unstructured":"Mocanua A, Furtos G, Rapuntean S et al (2014) Synthesis; characterization and antimicrobial effects of composites based on multi-substituted hydroxyapatite and silver nanoparticles. Appl Surf Sci 298:225\u2013235","journal-title":"Appl Surf Sci"},{"key":"1933_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1472-765X.2012.03219.x","volume":"54","author":"D Monteiro","year":"2012","unstructured":"Monteiro D, Silva S, Negri M, Gorup L, De Camargo E et al (2012) Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms. Lett Appl Microbiol 54:383\u2013391","journal-title":"Lett Appl Microbiol"},{"key":"1933_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1166\/jbn.2007.041","volume":"3","author":"L Nair","year":"2007","unstructured":"Nair L, Laurencin C (2007) Silver nanoparticles: synthesis and therapeutic applications. J Biomed Nanotechnol 3:301\u2013316","journal-title":"J Biomed Nanotechnol"},{"key":"1933_CR53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.micinf.2011.06.009","volume":"13","author":"J Naglik","year":"2011","unstructured":"Naglik J, Moyes D, Achtler B, Hube B (2011) Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect 13:963\u2013976","journal-title":"Microbes Infect"},{"key":"1933_CR31","first-page":"233","volume":"1","author":"A Nasrollahi","year":"2011","unstructured":"Nasrollahi A, Pourshamsian K, Mansourkiaee P (2011) Antifungal activity of silver nanoparticles on some of fungi. Int J Nanodimens 1:233\u2013239","journal-title":"Int J Nanodimens"},{"key":"1933_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mycmed.2012.04.004","volume":"22","author":"T No\u00ebl","year":"2012","unstructured":"No\u00ebl T (2012) The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs. J Mycol Med 22:173\u2013178","journal-title":"J Mycol Med"},{"key":"1933_CR33","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/AEM.02218-06","volume":"73","author":"S Pal","year":"2007","unstructured":"Pal S, Kyung Y, Song J (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712\u20131720","journal-title":"Appl Environ Microbiol"},{"key":"1933_CR34","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/smll.200700378","volume":"3","author":"Y Pan","year":"2007","unstructured":"Pan Y, Neuss S, Leifert A, Fischler M et al (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941\u20131949","journal-title":"Small"},{"key":"1933_CR35","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1016\/j.biomaterials.2009.07.065","volume":"30","author":"A Panacek","year":"2009","unstructured":"Panacek A, Kolar M, Vecerova R et al (2009) Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 30:6333\u20136340","journal-title":"Biomaterials"},{"key":"1933_CR36","first-page":"1717","volume":"9","author":"D Paredes","year":"2014","unstructured":"Paredes D, Ortiz C, Torres R (2014) Synthesis, characterization, and evaluation of antibacterial effect of Ag nanoparticles against Escherichia coli O157:h7 and methicillin-resistant Staphylococcus aureus (MRSA). Int J Nanomed 9:1717\u20131729","journal-title":"Int J Nanomed"},{"key":"1933_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mseb.2008.06.021","volume":"152","author":"A Petica","year":"2008","unstructured":"Petica A, Gavriliu S, Lungu M, Buruntea N, Panzaru C (2008) Colloidal silver solutions with antimicrobial properties. Mater Sci Eng B Solid State Mater Adv Technol 152:22\u201327","journal-title":"Mater Sci Eng B Solid State Mater Adv Technol"},{"key":"1933_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"M Pfaller","year":"2007","unstructured":"Pfaller M, Diekema D (2007) Epidemiology of invasive candidiasis a persistent public health problem. Clin Microbiol Rev 20:133\u2013163","journal-title":"Clin Microbiol Rev"},{"key":"1933_CR39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","volume":"46","author":"M Pfaller","year":"2008","unstructured":"Pfaller M, Diekema D, Gibbs D et al (2008) Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. J Clin Microbiol 46:515\u2013521","journal-title":"J Clin Microbiol"},{"key":"1933_CR40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","volume":"55","author":"M Pfaller","year":"2011","unstructured":"Pfaller M, Moet G, Messer S, Jones R et al (2011) Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY antimicrobial surveillance program, 2008\u20132009. Antimicrob Agents Chemother 55:561\u2013566","journal-title":"Antimicrob Agents Chemother"},{"key":"1933_CR41","volume-title":"Biosynthesis of silver nanoparticles and its antibacterial and antifungal activities towards Gram-positive","author":"Al-Thabaiti S Rahisuddin","year":"2015","unstructured":"Rahisuddin Al-Thabaiti S, Khan Z, Manzoor N (2015) Biosynthesis of silver nanoparticles and its antibacterial and antifungal activities towards Gram-positive. Bioprocess Biosyst Eng, Gram-negative bacterial strains and different species of Candida fungus. doi: 10.1007\/s00449-015-1418-3"},{"key":"1933_CR42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biotechadv.2008.09.002","volume":"27","author":"M Rai","year":"2009","unstructured":"Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76\u201383","journal-title":"Biotechnol Adv"},{"key":"1933_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","volume":"16","author":"C Rodloff","year":"2011","unstructured":"Rodloff C, Koch D, Schaumann R (2011) Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res 16:187\u2013195","journal-title":"Eur J Med Res"},{"key":"1933_CR44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00253-012-4209-7","volume":"97","author":"A Rodrigues","year":"2013","unstructured":"Rodrigues A, Ping L, Marcato P, Alves O, Silva M (2013) Biogenic antimicrobial silver nanoparticles produced by fungi. Appl Microbiol Biotechnol 97:775\u2013782","journal-title":"Appl Microbiol Biotechnol"},{"key":"1933_CR45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","volume":"86","author":"E Russell","year":"2011","unstructured":"Russell E (2011) Current concepts in antifungal pharmacology. Mayo Clin Proc 86:805\u2013817","journal-title":"Mayo Clin Proc"},{"key":"1933_CR46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"J Sardi","year":"2013","unstructured":"Sardi J, Scorzoni L, Bernardi T et al (2013) Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10\u201324","journal-title":"J Med Microbiol"},{"key":"1933_CR47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.colsurfb.2013.06.045","volume":"111","author":"T Shanmugasundaram","year":"2013","unstructured":"Shanmugasundaram T, Radhakrishnan M, Gopikrishnana V, Pazhanimurugan R, Balagurunathan R (2013) A study of the bactericidal, anti-biofouling, cytotoxic and antioxidant properties of actinobacterially synthesised silver nanoparticles. Colloids Surf B Biointerfaces 111:680\u2013687","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1933_CR48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cis.2008.09.002","volume":"145","author":"V Sharma","year":"2009","unstructured":"Sharma V, Yngard R, Lin Y (2009) Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 145:83\u201396","journal-title":"Adv Colloid Interface Sci"},{"key":"1933_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12088-014-0508-2","volume":"55","author":"P Szwesda","year":"2015","unstructured":"Szwesda P, Gucwa K, Kurzyk E, Romanowska E, Dzier\u017canowska-Fangrat K et al (2015) Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates. Indian J Microbiol 55:175\u2013183","journal-title":"Indian J Microbiol"},{"key":"1933_CR50","first-page":"527","volume":"86","author":"P Van-Tassel","year":"2013","unstructured":"Van-Tassel P (2013) Nanotechnology in medicine: nanofilm biomaterials. Yale J Biol Med 86:527\u2013536","journal-title":"Yale J Biol Med"},{"key":"1933_CR51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent S et al (2004) Nosocomial bloodstream infectionsin US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309\u2013317","journal-title":"Clin Infect Dis"},{"key":"1933_CR52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/smll.200900126","volume":"5","author":"H Yen","year":"2009","unstructured":"Yen H, Hsu S, Tsai C (2009) Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5:1553\u20131561","journal-title":"Small"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-015-1933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11274-015-1933-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-015-1933-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:01:24Z","timestamp":1559394084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11274-015-1933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s11274-015-1933-z","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}